A phase I/II open-label study of PAT-LM1 in patients with stage IV solid tumours.
Phase of Trial: Phase I/II
Latest Information Update: 11 Aug 2010
At a glance
- Drugs PAT LM1 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2010 Status changed from not stated to planning.
- 03 Aug 2010 The trial is expected to commence in the second half of 2011, according to a Patrys media release.
- 03 Aug 2010 New trial record